相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Magnitude, Specificity, and Avidity of Sporozoite-Specific Antibodies Associate With Protection Status and Distinguish Among RTS,S/AS01 Dose Regimens
S. Moses Dennison et al.
OPEN FORUM INFECTIOUS DISEASES (2021)
Breadth of humoral immune responses to the C-terminus of the circumsporozoite protein is associated with protective efficacy induced by the RTS,S malaria vaccine
Sidhartha Chaudhury et al.
VACCINE (2021)
Structural and biophysical correlation of anti-NANP antibodies with in vivo protection against P. falciparum
Tossapol Pholcharee et al.
NATURE COMMUNICATIONS (2021)
Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial
Mehreen S. Datoo et al.
LANCET (2021)
Avid binding by B cells to the Plasmodium circumsporozoite protein repeat suppresses responses to protective subdominant epitopes
Deepyan Chatterjee et al.
CELL REPORTS (2021)
A Monoclonal Antibody for Malaria Prevention
M. R. Gaudinski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
RTS,S/AS01 vaccine (Mosquirix?): an overview
Matthew B. Laurens
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
Diverse Antibody Responses to Conserved Structural Motifs in Plasmodium falciparum Circumsporozoite Protein
Tossapol Phoicharee et al.
JOURNAL OF MOLECULAR BIOLOGY (2020)
Structure and mechanism of monoclonal antibody binding to the junctional epitope of Plasmodium falciparum circumsporozoite protein
David Oyen et al.
PLOS PATHOGENS (2020)
Characterization of two in vivo challenge models to measure functional activity of monoclonal antibodies to Plasmodium falciparum circumsporozoite protein
Rama Raghunandan et al.
MALARIA JOURNAL (2020)
Evolution of protective human antibodies against Plasmodium falciparum circumsporozoite protein repeat motifs
Rajagopal Murugan et al.
NATURE MEDICINE (2020)
Antibody Feedback Limits the Expansion of B Cell Responses to Malaria Vaccination but Drives Diversification of the Humoral Response
Hayley A. McNamara et al.
CELL HOST & MICROBE (2020)
Mapping functional humoral correlates of protection against malaria challenge following RTS,S/AS01 vaccination
Todd J. Suscovich et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
A Potent Anti-Malarial Human Monoclonal Antibody Targets Circumsporozoite Protein Minor Repeats and Neutralizes Sporozoites in the Liver
Lawrence T. Wang et al.
IMMUNITY (2020)
Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S/ASO1E malaria vaccine efficacy
Carlota Dobano et al.
NATURE COMMUNICATIONS (2019)
Optimization of an in vivo model to study immunity to Plasmodium falciparum pre-erythrocytic stages
Yevel Flores-Garcia et al.
MALARIA JOURNAL (2019)
Rare PfCSP C-terminal antibodies induced by live sporozoite vaccination are ineffective against malaria infection
Stephen W. Scally et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
A public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite protein
Joshua Tan et al.
NATURE MEDICINE (2018)
A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite
Neville K. Kisalu et al.
NATURE MEDICINE (2018)
Antihomotypic affinity maturation improves human B cell responses against a repetitive epitope
Katharina Imkeller et al.
SCIENCE (2018)
Cryo-EM structure of P. falciparum circumsporozoite protein with a vaccine-elicited antibody is stabilized by somatically mutated inter-Fab contacts
David Oyen et al.
SCIENCE ADVANCES (2018)
Natural Parasite Exposure Induces Protective Human Anti-Malarial Antibodies
Gianna Triller et al.
IMMUNITY (2017)
Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial
Mahamadou S. Sissoko et al.
LANCET INFECTIOUS DISEASES (2017)
Structural basis for antibody recognition of the NANP repeats in Plasmodium falciparum circumsporozoite protein
David Oyen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study
Jason A. Regules et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Seven-Year Efficacy of RTS, S/AS01 Malaria Vaccine among Young African Children
Ally Olotu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Proteolytic Cleavage of the Plasmodium falciparum Circumsporozoite Protein Is a Target of Protective Antibodies
Diego A. Espinosa et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial
Michael T. White et al.
LANCET INFECTIOUS DISEASES (2015)
Genetic Diversity and Protective Efficacy of the RTS, S/AS01 Malaria Vaccine
D. E. Neafsey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
High-throughput sequencing of natively paired antibody chains provides evidence for original antigenic sin shaping the antibody response to influenza vaccination
Yann-Chong Tan et al.
CLINICAL IMMUNOLOGY (2014)
Artemisinin resistance - modelling the potential human and economic costs
Yoel Lubell et al.
MALARIA JOURNAL (2014)
Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites
Selidji Todagbe Agnandji et al.
PLOS MEDICINE (2014)
Malaria vaccine technology roadmap
Vasee S. Moorthy et al.
LANCET (2013)
Identification of Anti-Alpha Toxin Monoclonal Antibodies That Reduce the Severity of Staphylococcus aureus Dermonecrosis and Exhibit a Correlation between Affinity and Potency
C. Tkaczyk et al.
CLINICAL AND VACCINE IMMUNOLOGY (2012)
Genetic Variation in the Plasmodium falciparum Circumsporozoite Protein in India and Its Relevance to RTS,S Malaria Vaccine
Mohammad Zeeshan et al.
PLOS ONE (2012)
Unexpected fold in the circumsporozoite protein target of malaria vaccines
Michael B. Doud et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children
Selidji Todagbe Agnandji et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
MolProbity: all-atom structure validation for macromolecular crystallography
Vincent B. Chen et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
Features and development of Coot
P. Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Paul D. Adams et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
Structure of the Plasmodium falciparum Circumsporozoite Protein, a Leading Malaria Vaccine Candidate
Matthew L. Plassmeyer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
T-cell epitope polymorphisms of the Plasmodium falciparum circumsporozoite protein among field isolates from Sierra Leone: age-dependent haplotype distribution?
Amadu Jalloh et al.
MALARIA JOURNAL (2009)
Heparan sulfate proteoglycans provide a signal to Plasmodium sporozoites to stop migrating and productively invade host cells
Alida Coppi et al.
CELL HOST & MICROBE (2007)
Phaser crystallographic software
Airlie J. McCoy et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)
Function of region I and II adhesive motifs of Plasmodium falciparum circumsporozoite protein in sporozoite motility and infectivity
R Tewari et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Proteoglycans mediate malaria sporozoite targeting to the liver
G Pradel et al.
MOLECULAR MICROBIOLOGY (2002)
分享论文
